This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (1151)
-
May 21, 2025 | Official Statement Novartis, Teva, others receive warning letters from US FTC over Orange Book patents
...and Drug Administration's Orange Book across 17 different brand-name products....
Sections: Antitrust, Energy, Intellectual Property, and Technology
-
May 20, 2025 | Insight As inventive steps become smaller, trade secret protections grow in importance
...Pharmaceutical compositions, for example, enter the public domain via the US Food and Drug Administration...
Sections: Intellectual Property
-
May 15, 2025 | Comment Trump executive orders on competition put spotlight on federal regulations
...The US Defense Department, the Environmental Protection Agency and the Food and Drug Administration are...
Sections: Antitrust
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login